Risk of intracranial hemorrhage in patients using anticoagulant therapy for atrial fibrillation after cerebral microbleeds combined with acute ischemic stroke: a meta-analysis
ConclusionAnticoagulant therapy for ischemic stroke patients with non-valvular AF and CMBs increases future ICH risk. Discontinuing anticoagulation due to ICH risk should be avoided. NOACs are safe and effective for patients with CMBs and IS.
Source: Frontiers in Neurology - Category: Neurology Source Type: research
More News: Atrial Fibrillation | Brain | Databases & Libraries | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Stroke | Vitamin K | Vitamins